Pharmacokinetics of Cotadutide in Participants With Hepatic Impairment

Clinical trial NCT05517226 · TERMINATED

Trial details

NCT number: NCT05517226
Sponsor: AstraZeneca
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Hepatic Impairment

Start date: 2022-09-06
Primary completion: 2023-02-27
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.